Skip to content
Menu

JP Morgan Maintains Overweight on Biohaven, Raises Price Target to $35

Benzinga Newsdesk 2 days ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

JP Morgan analyst Tessa Romero maintains Biohaven (NYSE:BHVN) with a Overweight and raises the price target from $14 to $35.

JP Morgan analyst Tessa Romero maintains Biohaven (NYSE:BHVN) with a Overweight and raises the price target from $14 to $35.

Read at benzinga.com

← All stock news